Viewing Study NCT03843359

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:02 PM
Ignite Modification Date: 2026-02-04 @ 5:35 AM
Study NCT ID: NCT03843359
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-08-09
First Post: 2019-02-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GSK3745417 View
None Dostarlimab View
None Anti-Programmed death receptor-1 (PD-1) View
None Monoclonal antibody View
None Solid tumor View
None First time in human View
None Stimulator of Interferon Genes View
None STING View